Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.20.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balance at Mar. 31, 2018 $ 5 $ 889,650 $ (862,225) $ (1,658) $ 25,772
Balance (in shares) at Mar. 31, 2018 5,726,011     14,596  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (114) (114)
Purchase of treasury stock (in shares)       11,643  
Vested restricted stock awards   113     113
Vested restricted stock awards (in shares) 29,700        
Stock-based compensation   907     907
Exercise of employee stock purchases   1     $ 1
Exercise of employee stock purchases (in shares) 102       101
Stock awards to Board of Directors   (70)     $ (70)
Stock awards to Board of Directors (in shares) 45,719        
Issuance of common stock, net of issuance costs $ 1 10,934     10,935
Issuance of common stock, net of issuance costs (in shares) 1,034,757        
Warrants exercised $ 1 (4)     (3)
Warrants exercised (in shares) 380,621        
Warrants issued   2,272     2,272
Net loss     (16,659)   (16,659)
Balance at Mar. 31, 2019 $ 7 903,803 (878,884) $ (1,772) $ 23,154
Balance (in shares) at Mar. 31, 2019 7,216,910     26,239 7,190,671
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (103) $ (103)
Purchase of treasury stock (in shares)       31,338  
Vested restricted stock awards   102     102
Vested restricted stock awards (in shares) 73,983        
Stock-based compensation   913     913
Exercise of employee stock purchases   3     $ 3
Exercise of employee stock purchases (in shares) 522       522
Stock awards to Board of Directors   (24)     $ (24)
Stock awards to Board of Directors (in shares) 26,315        
Issuance of common stock, net of issuance costs $ 2 10,580     10,582
Issuance of common stock, net of issuance costs (in shares) 2,528,636        
Warrants exercised $ 1       1
Warrants exercised (in shares) 440,000        
Change in warrants valuation   291     291
Deemed dividend on purchase warrant for common shares   87 (87)    
Net loss     (21,898)   (21,898)
Balance at Mar. 31, 2020 $ 10 $ 915,755 $ (900,869) $ (1,875) $ 13,021
Balance (in shares) at Mar. 31, 2020 10,286,366     57,577 10,228,789